SINOMED(SH:688108) Ge Long Hui·2025-10-31 08:21Core Viewpoint - Sino Medical's TRADENTTM coronary stent balloon dilation catheter has received approval from the Ministry of Food and Drug Safety (MFDS) in South Korea, marking a significant advancement in the treatment of coronary artery stenosis [1][2] Group 1: Product Approval and Features - The TRADENTTM catheter is the first of its kind in the domestic market to receive approval, specifically designed for percutaneous transluminal coronary angioplasty (PTCA) to treat vascular stenosis [1] - The product features a spiral layout of thorn wires on the balloon surface, enhancing its embedding capability while maintaining good passability [1] - The balloon can effectively lock onto calcified plaques and perform 360° plaque stripping, allowing for controlled and efficient pre-treatment [1] Group 2: Clinical Benefits - The approval of the TRADENTTM catheter is expected to improve the shortcomings of conventional balloon dilation catheters, increasing the success rate of lesion dilation [2] - It aims to reduce the risk of complications such as vascular perforation and damage to normal vessel walls, providing physicians with more clinical options [2] - Patients are anticipated to benefit from enhanced clinical outcomes due to the improved design and functionality of the catheter [2]